Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Ampullary Adenocarcinoma × Capecitabine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 12 Rectal Neoplasms 8 Colorectal Neoplasms 7 Stomach Neoplasms 3 Solid Tumor 1 Recurrence 1 Neoplasms 1 Microbiota 1 Gallbladder Neoplasms 1 Fruquintinib 1 Elderly Metastatic Colorectal Cancer Patients 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Breast Cancer Organoids 1 Breast Cancer Metastatic 1 Biliary Tract Neoplasms 1 Ampullary Adenocarcinoma 1

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡